Position in AZN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,169,286
-$235,433 QoQ
Shares Held
32,535
+0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#363
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RNC CAPITAL MANAGEMENT LLC holds $281,592,319 across 11 Drug Manufacturers - General names. AZN ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
517,240 | $66,465,340 | |
| 2 | ABBV |
AbbVie Inc.
|
236,727 | $59,569,982 | |
| 3 | JNJ |
Johnson & Johnson
|
191,013 | $48,511,571 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
356,290 | $45,013,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
645,383 | $37,186,968 | |
| 6 | LLY |
ELI LILLY & Co
|
13,549 | $16,251,078 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
32,535 | $6,169,286 | |
| 8 | AMGN |
Amgen Inc
|
2,755 | $997,640 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,169,286 | 32,535 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,404,719 | 32,475 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||